Objective: To assess tumor markers in oropharynx cancer.
Design: Marker expression and clinical outcome.
Setting: Laboratory.
Patients: Forty-two patients with advanced oropharyngeal cancer treated with chemoradiation therapy.
Intervention: Treatment with chemoradiation therapy.
Main Outcome Measures: Expression of p53 and Bcl-xL in tumor tissues was assessed for correlation with chemotherapy response and survival.